Lisse Decraecker
Appearances
DateMay 18, 2024Our previous pilot study showed that treatment with the histamine 1 receptor antagonist ebastine improved symptoms in patients with irritable bowel syndrome (IBS)…Presenter
Speakers
Amsterdam UMC, University of Amsterdam
DateMay 18, 2024TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIALModerators
Mayo Clinic ScottsdaleCleveland ClinicSpeakers
University of MichiganMichigan Medicine
